Skip to main content

View full-text article in PMC

. 2022 Jun 9;9:852022. doi: 10.3389/fmed.2022.852022

TABLE 6.

Changes of OCT biomarkers presentation in groups and by final BCVA response.

	Group by final BCVA response
	VA improved (Δ LogMAR < 0)		VA not improved (Δ LogMAR ≥ 0)
	Pre	After	Pre	After
DRIL	22/33 (72.7%)	15/33 (45.5%)^*	27/31 (87.1%)	18/31 (58.1%)^*
SRF	6/33 (18.2%)	1/33 (3.0%)^*	9/31 (29.0%)	4/31 (12.9%)
LONLC	9/33 (27.3%)	3/33 (9.1%)	11/31 (35.5%)	4/31 (12.9%)^*
IRC	28/33 (84.9%)	22/33 (66.7%)	25/31 (80.7%)	20/31 (64.5%)
EZD	17/33 (51.5%)	9/33 (27.3%)^*	17/31 (54.8%)	16/31 (51.6%)

*p < 0.05, compared to pre-study, by Chi-Square test.